| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/08/2010 | US7732576 for identification on human chromosome 10 of a tumor suppressor gene; |
| 06/08/2010 | US7732575 Proteins bonded to solid supports |
| 06/08/2010 | US7732417 Methods and compositions for RNA interference using recombinant Dicer and Argonaut |
| 06/08/2010 | US7732410 applying an antiproliferative agent capable of removing sialic acid residues, such as trans-sialidase, neuraminidase with plant extracts comprising nucleic acid-containing particles from garlic, ginkgo, tomato, orchid, guava, ginseng, ginger, and tobacco; anticholesterol agent |
| 06/08/2010 | US7732409 EspFU nucleic acids and proteins and uses thereof |
| 06/08/2010 | US7732402 Mammalian telomerase |
| 06/08/2010 | US7732377 Methods for producing members of specific binding pairs |
| 06/08/2010 | US7732207 Method for expression of small antiviral RNA molecules within a cell |
| 06/08/2010 | US7732201 neural cells comprising a neuroblast and a nestin-positive neural cell; for treating neuronal disorders |
| 06/08/2010 | US7732197 Recombinant nucleic acid of a nucleotide sequence encoding an autocatalytically cleaving and trans-acting ribozymes linked to a tissue-specific or pathogen-specific promoter; anticancer or antiproliferative agents |
| 06/08/2010 | US7732193 Expressing preferential nucleotide sequences in cells; obtain cell, transfect, recover packaged retrovirus, infect target cell, monitor gene expression in cell |
| 06/08/2010 | US7732185 Plasmid having response to dioxins, transgenic cell for measuring dioxins, dioxins sensing method and biosensor using the same |
| 06/08/2010 | US7732181 Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
| 06/08/2010 | US7732179 Mutants of pyrroloquinoline quinone dependent soluble glucose dehydrogenase |
| 06/08/2010 | US7732178 Laccase enzymes and their uses |
| 06/08/2010 | US7732177 Inactive 2',5' Oligo-adenylate synthetase (OAS) for use as viricidal and antitumor therapeutic |
| 06/08/2010 | US7732169 Method for detecting West Nile virus nucleic acids in the 5′ non-coding/capsid region |
| 06/08/2010 | US7732162 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor such as 1-(3-(1H-imidazole-1-yl)propyl)-3-(3,4-dimethoxy-phenyl)thiourea hydrochloride; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders; dementia |
| 06/08/2010 | US7732161 fermentation method that converts hydroxymethylglutaryl-CoA to L-mevalonic acid and eventually to isoprenoids (farnesol and geranylgeraniol ) |
| 06/08/2010 | US7732159 Using plasminogin activator concentration as indicator of tumor progress and antitumor drug efficacy |
| 06/08/2010 | US7732155 Using sequence similarity to identify preferential acytransferases; enhancing polyunsaturated fatty acids (PUFA), and oils in cells |
| 06/08/2010 | US7732151 insulin receptor substrate (IRS) proteins; assay for determining the ability of an enzyme, functional fragment, or functional derivative thereof to modify the phosphorylation status of a biotinylated polypeptide |
| 06/08/2010 | US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor |
| 06/08/2010 | US7732145 Method and devices for rapid diagnosis of foot-and-mouth disease |
| 06/08/2010 | US7732144 assessing levels of expression of Thymidylate Synthase (TS) and Excision Repair Cross-Complementing (ERCC1) mRNA obtained from fixed or fixed and paraffin-embedded (FPE) tumor cells |
| 06/08/2010 | US7732143 characterized by substantial impairments of the genome, either in its structure, deletion or translocation and methods which allow genes to be located and mapped rapidly |
| 06/08/2010 | US7732142 Sequences diagnostic for shrimp pathogens |
| 06/08/2010 | US7732141 Methods for evaluating drug-resistance gene expression in the cancer patient |
| 06/08/2010 | US7732140 Method for direct electrical detection of molecules and molecule-molecule interactions |
| 06/08/2010 | US7732139 Multiple SNP for diagnosing cardiovascular disease, microarray and kit comprising the same, and method of diagnosing cardiovascular disease using the same |
| 06/08/2010 | US7732138 use of Allele-Specific-Oligonucleotide (ASO) as a detection assay for human Human Leukocytic Antigens (HLA) classification; rapid, definitive and accurate; genomic analysis; forensics; paternity testing |
| 06/08/2010 | US7732137 Selecting animals for desired genotypic or potential phenotypic properties |
| 06/08/2010 | US7732136 Using multicompartment apparatus for cyclic propagation of preferential nucleotide sequences; DNA amplification |
| 06/08/2010 | US7732135 comprises variants of IL-4 receptor alpha, IL13 and CD14; determining an individual's propensity to a peanut allergy, eczema |
| 06/08/2010 | US7732134 Methods to predict cholesterol elevation during immunosuppressant therapy |
| 06/08/2010 | US7732132 hybridoma cell line that produces a monoclonal antibody against the NSs proteins of WSMoV-serogroup tospoviruses |
| 06/08/2010 | US7732131 Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor |
| 06/08/2010 | US7732130 Immunoprotective influenza antigen and its use in vaccination |
| 06/08/2010 | US7732129 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation |
| 06/08/2010 | US7732128 Apparatus which utilizes atp concentration as a diagnostic indicator of cell viability; high throughput assay and cancer drug screening |
| 06/08/2010 | US7732127 Dynamic monitoring of cell adhesion and spreading using the RT-CES system |
| 06/08/2010 | US7731980 Polymorphic membrane proteins (pmp), amino acid and nucleotide sequences, antibodies specific for polymorphic membrane proteins, polypeptides, prophylactic and therapeutic compositions |
| 06/08/2010 | US7731967 Compositions for inducing immune responses |
| 06/08/2010 | US7731956 Exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to ultraviolet radiation or heat; administered following a contusion or spinal cord injury to the central nervous system |
| 06/08/2010 | US7731835 monitoring analyte glucose concentration in a biological fluid by applying a potential to the electrode, comparison with known concentrations of the analyte in medium |
| 06/08/2010 | US7731828 Method for rapid typification of microorganisms and set of reagents used |
| 06/08/2010 | CA2422295C A gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene |
| 06/08/2010 | CA2369010C Method for determining level of folate in a biological sample |
| 06/08/2010 | CA2368135C Xylo-lna analogues |
| 06/08/2010 | CA2343010C Card for counting and characterising micro-organisms |
| 06/08/2010 | CA2322019C Mass spectrometric methods for biomolecular screening |
| 06/08/2010 | CA2320390C Pna and dna conjugates and methods for preparation thereof |
| 06/08/2010 | CA2158047C Allergenic protein and peptides from house dust mite and uses therefor |
| 06/08/2010 | CA2144475C Polyamide-oligonucleotide derivatives, their preparation and use |
| 06/08/2010 | CA1341606C Activation of nf-kb precursor |
| 06/05/2010 | CA2645883A1 Selective detection of human rhinovirus |
| 06/03/2010 | WO2010063011A2 Methods for the treatment of infections and tumors |
| 06/03/2010 | WO2010062960A2 METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
| 06/03/2010 | WO2010062951A2 Animal model for osteoarthritis and intervertebral disc disease |
| 06/03/2010 | WO2010062914A1 Methods for identifying cancer risk |
| 06/03/2010 | WO2010062909A1 Broad range pcr-based compositions and methods for the detection and identification of fungal pathogens |
| 06/03/2010 | WO2010062903A2 Genomic sequencing using modified protein pores and ionic liquids |
| 06/03/2010 | WO2010062897A1 Methods and compositions to detect clostridium difficile |
| 06/03/2010 | WO2010062801A1 Nanoparticulate affinity capture for label independent detection system |
| 06/03/2010 | WO2010062781A2 Methods, kits, and reaction mixtures for high resolution melt genotyping |
| 06/03/2010 | WO2010062775A2 Methods for detecting modification resistant nucleic acids |
| 06/03/2010 | WO2010062763A1 Gene expression profiling for predicting the survivability of melanoma subjects |
| 06/03/2010 | WO2010062738A1 Diagnosis and treatment of congenital heart defects using nell 1 |
| 06/03/2010 | WO2010062706A2 Methods for assessing rna patterns |
| 06/03/2010 | WO2010062697A2 Membrane-integrated viral dna-packaging motor protein connector biosensor for dna sequencing and other uses |
| 06/03/2010 | WO2010062683A2 Structure for molecular separations |
| 06/03/2010 | WO2010062654A2 Device and method for the study of cell and tissue function |
| 06/03/2010 | WO2010062650A2 Neamine compositions and methods of use thereof |
| 06/03/2010 | WO2010062556A1 Fast results hybrid capture assay and system |
| 06/03/2010 | WO2010062546A1 Fast results hybrid capture assay on an automated platform |
| 06/03/2010 | WO2010062472A1 Methods and systems for measuring microbiological content in aqueous media |
| 06/03/2010 | WO2010062404A2 N-fmoc nucleosides and phosphoramidites, and oligonucleotide synthesis |
| 06/03/2010 | WO2010062365A2 A method of protecting against heart failure |
| 06/03/2010 | WO2010062354A1 Methods for separation, characterization, and/or identification of microorganisms using mass spectrometry |
| 06/03/2010 | WO2010062352A1 Methods for the isolation and identification of microorganisms |
| 06/03/2010 | WO2010062350A1 Methods for detection, characterization and/or identification of microorganisms in a sealed container |
| 06/03/2010 | WO2010062349A1 Methods for separation and characterization of microorganisms using identifier agents |
| 06/03/2010 | WO2010062344A1 Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis pmpa gene |
| 06/03/2010 | WO2010062317A1 Compositions and methods for detecting food-borne pathogens |
| 06/03/2010 | WO2010062001A1 Dna chip, kit for detecting or genotyping bacteria causing sexually transmitted diseases, genotyping antibacterial drug resistance and detecting or genotyping method using the same |
| 06/03/2010 | WO2010061996A1 Diagnostic kit of colon cancer using colon cancer related marker, and diagnostic method therof |
| 06/03/2010 | WO2010061981A1 Method for measuring cytokeratin-19 mrna |
| 06/03/2010 | WO2010061922A1 NOVEL MutS PROTEIN AND METHOD OF USING SAME TO DETERMINE MUTATIONS |
| 06/03/2010 | WO2010061892A1 Novel variable lymphocyte receptor, method for screening for phage capable of binding to target antigen, and method for producing variable lymphocyte receptor for target antigen |
| 06/03/2010 | WO2010061697A1 Gene sensitive to normal-tension glaucoma disease, and use thereof |
| 06/03/2010 | WO2010061638A1 Selection of target gene for anti-fungal agent, and method for predicting function of the target gene |
| 06/03/2010 | WO2010061407A1 Genetic variants useful for risk assessment of thyroid cancer |
| 06/03/2010 | WO2010061396A1 Methods for detecting an increased susceptibility to cancer |
| 06/03/2010 | WO2010061393A1 He4 variant nucleotide and amino acid sequences, and methods of use thereof |
| 06/03/2010 | WO2010061351A1 Oligonucleotides for the detection of aspergillus species |
| 06/03/2010 | WO2010061347A1 Pcr based diagnostic method for the identification of clinically important candida species |
| 06/03/2010 | WO2010061246A1 Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment |
| 06/03/2010 | WO2010061202A1 Assay |
| 06/03/2010 | WO2010061185A2 Therapeutic target |
| 06/03/2010 | WO2010061023A1 Colorectal cancer diagnostic method |